3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
39
Ovarian Neoplasms
33
Triple Negative Breast Neoplasms
19
Prostatic Neoplasms
17
Fallopian Tube Neoplasms
16
Neoplasm Metastasis
14
Pancreatic Neoplasms
9
Neoplasms
9
Endometrial Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Small Cell Lung Carcinoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Glioma
6
Stomach Neoplasms
5
Sarcoma
5
Lung Neoplasms
5
Glioblastoma
5
Squamous Cell Carcinoma of Head and Neck
4
Metastatic Castration-resistant Prostate Cancer
4
Carcinoma, Ovarian Epithelial
4
Solid Tumors
3
Recurrence
3
Osteosarcoma
3
Neuroendocrine Tumors
3
Lymphoma, Non-Hodgkin
3
Cholangiocarcinoma
3
Urinary Bladder Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Prostatic Neoplasms, Castration-Resistant
2
Interventions
Radiotherapy
6
Chemoradiotherapy
2
sodium propionate
1
olaparib
1
Xylitol
1
Surgical Procedures, Operative
1
Re-Irradiation
1
Radiography, Panoramic
1
Poly A
1
Oral Hygiene
1
Menogaril
1
Lymph Node Excision
1
Lisinopril
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Fatty Acids, Volatile
1
Dexamethasone
1
Consolidation Chemotherapy
1
Butyric Acid
1
Blood Specimen Collection
1
Bevacizumab
1
Betaine
1
Androgen Antagonists
1
Adrenal Cortex Hormones
1
Adenosine Diphosphate Ribose
1
Adenosine Diphosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiation Injuries
×
olaparib
×
1 year
×
Clear all
NCT03109080
2025-11-24
RadioPARP
Institut Curie
Phase 1
Completed
24 enrolled